The developer has applied for a study of the triple administration of "KoviVac"

Center them. M.P. Chumakova sent an application to the Ministry of HEALTH for conducting clinical trials of the three-time administration of the CoviVac CORONAVIRUS vaccine, DIRECTOR of the institution Aidar Ishmukhametov said on the Rossiya 24 TV channel.

“The Chumakov Institute applied to the clinic (clinical studies. -) for three injections. Three times administration after 21 days,” he said.

According to the director of the center, the use of booster vaccination against the omicron strain of coronavirus is the only possible approach in the fight against it today.

The Center also hopes to have CoviVac registered with the World Health Organization (WHO) within six months. The developer has already tripled the production of the vaccine; in 2022, the center plans to produce at least 25 million doses of CoviVac.

The Chumakov Center's CoviVac vaccine is the only Russian product for immunization against covid-19 that contains a whole inactivated SARS-CoV-2 coronavirus.

At the end of September, the president of the pharmaceutical company Nanolek, the manufacturer of KoviVak, Vladimir Khristenko, said that the demand for the vaccine could not be met until 2022.

On December 17, RDIF announced that the third dose of the Sputnik V vaccine against Omicron was 80% effective, citing data from a study by the Gamaleya Center.

The developers of the vaccine noted that when revaccinated with Sputnik Light (one dose of Sputnik V), 100% of people develop antibodies to Omicron and remain at a high level for two to three months.

Does it have the right to do so? What technologies does Alisher Usmanov, who sold his stake in VK, invest in? The world is waiting for a “super cycle” in non-ferrous metals. What stocks to look out for

Vaccination in regions of RUSSIA Number of doses of vaccine applied per 100 population of the region* first dose second dose *May not be equal to the share of the vaccinated population. The operational headquarters includes data on revaccination in the information on vaccination with the first and second dose. At the same time, he does not specify whether people who have been revaccinated once or several times are taken into account. Sources: Coronavirus Operational Headquarters, Rosstat, RBC calculations Data for Russia i